Gene ontology annotations for ACTA2 |
|
Experiment description of studies that identified ACTA2 in exosomes |
1 |
Experiment ID |
20 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP90|CD63|CD81|LAMP1
|
Enriched markers |
✔
GOLGA2|cytochrome c
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
17956143
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
Authors |
"Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS" |
Journal name |
JPR
|
Publication year |
2007 |
Sample |
Colorectal cancer cells |
Sample name |
HT29 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Diafiltration |
Flotation density |
1.16 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
2 |
Experiment ID |
207 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
3 |
Experiment ID |
208 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
4 |
Experiment ID |
209 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
5 |
Experiment ID |
189 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19530224
|
Organism |
Homo sapiens |
Experiment description |
Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. |
Authors |
"Chavez-Muñoz C, Kilani RT, Ghahary A." |
Journal name |
J Cell Physiol
|
Publication year |
2009 |
Sample |
Keratinocytes |
Sample name |
Keratinocytes - Differentiated |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose cushion Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
6 |
Experiment ID |
190 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSC70
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19530224
|
Organism |
Homo sapiens |
Experiment description |
Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. |
Authors |
"Chavez-Muñoz C, Kilani RT, Ghahary A." |
Journal name |
J Cell Physiol
|
Publication year |
2009 |
Sample |
Keratinocytes |
Sample name |
Keratinocytes - Undifferentiated |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose cushion Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
7 |
Experiment ID |
126 |
MISEV standards |
✘
|
Biophysical techniques |
✔
GAPDH
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
PubMed ID |
Unpublished / Not applicable
|
Organism |
Homo sapiens |
Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
Journal name |
Mesenchymal Stem Cell Therapy
|
Publication year |
2011 |
Sample |
Mesenchymal stem cells |
Sample name |
huES9.E1 |
Isolation/purification methods |
HPLC |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Antobody array Mass spectrometry |
|
|
8 |
Experiment ID |
488 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Homo sapiens |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Mesenchymal stem cells |
Sample name |
UCMSC |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
9 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
10 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
11 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
12 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
13 |
Experiment ID |
136 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
PC3 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
14 |
Experiment ID |
137 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB6|CD10
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
PC3 - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
15 |
Experiment ID |
140 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
VCaP - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
16 |
Experiment ID |
142 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
LNCaP - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
17 |
Experiment ID |
143 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
LNCaP - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
18 |
Experiment ID |
144 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
19 |
Experiment ID |
145 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD10
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
20 |
Experiment ID |
146 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
RWPE - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
21 |
Experiment ID |
834 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
LAMP2|CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
22 |
Experiment ID |
835 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
23 |
Experiment ID |
13 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
Alix|RAB4|RAB5B|RAB11|TSG101|CD9|AQP2|AQP1
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
15326289
|
Organism |
Homo sapiens |
Experiment description |
Identification and proteomic profiling of exosomes in human urine. |
Authors |
"Pisitkun T, Shen RF, Knepper MA" |
Journal name |
PNAS
|
Publication year |
2004 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LCQ DECA XP] Western blotting |
|
|
24 |
Experiment ID |
193 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD63|CD9
|
Enriched markers |
✔
PHB
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
21595033
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
Journal name |
Proteomics
|
Publication year |
2011 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
25 |
Experiment ID |
194 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
21595033
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
Journal name |
Proteomics
|
Publication year |
2011 |
Sample |
Urine |
Sample name |
Urine - Patients of basement membrane nephropathy |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
26 |
Experiment ID |
195 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
21595033
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
Journal name |
Proteomics
|
Publication year |
2011 |
Sample |
Urine |
Sample name |
Urine - Patients of early IgA nephropathy |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for ACTA2 |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
CRYGD |
|
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
RALY |
22913 |
Affinity Capture-MS |
|
Homo sapiens |
|
3 |
CAPNS2 |
84290 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
ZSCAN29 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
MAP1LC3C |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
6 |
UBE2H |
7328 |
Affinity Capture-MS |
|
Homo sapiens |
|
7 |
SCIN |
85477 |
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
SLCO1B3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
TWF2 |
11344 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
UBL4A |
8266 |
Affinity Capture-MS |
|
Homo sapiens |
|
11 |
GSTP1 |
2950 |
Co-fractionation |
|
Homo sapiens |
|
12 |
PEAR1 |
375033 |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
DHCR24 |
1718 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
14 |
ABRA |
|
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
PTMA |
5757 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
16 |
THRB |
7068 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
17 |
GPR34 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
NAA11 |
84779 |
Affinity Capture-MS |
|
Homo sapiens |
|
19 |
YWHAE |
7531 |
Co-fractionation |
|
Homo sapiens |
|
20 |
GC |
2638 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
21 |
CAP1 |
10487 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
22 |
ACTC1 |
70 |
Co-fractionation |
|
Homo sapiens |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
23 |
DBN1 |
1627 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
24 |
MYOC |
4653 |
Two-hybrid |
|
Homo sapiens |
|
25 |
UBE3A |
7337 |
Reconstituted Complex |
|
Homo sapiens |
|
26 |
CCT4 |
10575 |
Co-crystal Structure |
|
Homo sapiens |
|
27 |
RPL14 |
9045 |
Co-fractionation |
|
Homo sapiens |
|
28 |
MCCC1 |
56922 |
Affinity Capture-MS |
|
Homo sapiens |
|
29 |
MYH11 |
4629 |
Co-fractionation |
|
Homo sapiens |
|
30 |
CAND1 |
55832 |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
CBY1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
IL36A |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
33 |
LIM2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
ADAM19 |
8728 |
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
POTEF |
728378 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
36 |
THAP11 |
57215 |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
MRPS5 |
64969 |
Affinity Capture-MS |
|
Homo sapiens |
|
38 |
POTEE |
445582 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
39 |
ADAM21 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
40 |
C9orf43 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
41 |
REG3A |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
42 |
PECR |
55825 |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
ALOX12 |
239 |
Affinity Capture-Western |
|
Homo sapiens |
|
44 |
B3GNT2 |
10678 |
Affinity Capture-MS |
|
Homo sapiens |
|
45 |
SIRT2 |
22933 |
Affinity Capture-MS |
|
Homo sapiens |
|
46 |
FAM150B |
|
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
PFN3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
48 |
FAM53B |
|
Affinity Capture-MS |
|
Homo sapiens |
|
49 |
MCM2 |
4171 |
Affinity Capture-MS |
|
Homo sapiens |
|
50 |
GNAO1 |
2775 |
Affinity Capture-MS |
|
Homo sapiens |
|
51 |
LINC01587 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
52 |
PTPRZ1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
53 |
IL17RE |
|
Affinity Capture-MS |
|
Homo sapiens |
|
54 |
ACTG2 |
72 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
55 |
HEY1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
56 |
COPS5 |
10987 |
Affinity Capture-MS |
|
Homo sapiens |
|
57 |
DRG1 |
4733 |
Affinity Capture-MS |
|
Homo sapiens |
|
58 |
MUC1 |
4582 |
Affinity Capture-MS |
|
Homo sapiens |
|
59 |
KLF6 |
|
Proximity Label-MS |
|
Homo sapiens |
|
60 |
ACTR1A |
10121 |
Affinity Capture-MS |
|
Homo sapiens |
|
61 |
NAT6 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
62 |
NPVF |
|
Affinity Capture-MS |
|
Homo sapiens |
|
63 |
CNN2 |
1265 |
Co-fractionation |
|
Homo sapiens |
|
64 |
PCNX |
|
Affinity Capture-MS |
|
Homo sapiens |
|
65 |
CTSD |
1509 |
Affinity Capture-MS |
|
Homo sapiens |
|
66 |
WASH1 |
100287171 |
Affinity Capture-MS |
|
Homo sapiens |
|
67 |
LRRC20 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
68 |
KRT78 |
196374 |
Affinity Capture-MS |
|
Homo sapiens |
|
69 |
RANBP17 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
70 |
CALML5 |
51806 |
Affinity Capture-MS |
|
Homo sapiens |
|
71 |
RNF216 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
72 |
ST8SIA4 |
7903 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
73 |
EMCN |
|
Affinity Capture-MS |
|
Homo sapiens |
|
74 |
MAP3K6 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
75 |
ETFA |
2108 |
Affinity Capture-MS |
|
Homo sapiens |
|
76 |
SPRTN |
|
Affinity Capture-MS |
|
Homo sapiens |
|
77 |
MRPS7 |
51081 |
Co-fractionation |
|
Homo sapiens |
|
78 |
PFN2 |
5217 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
79 |
PLEC |
5339 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
80 |
CUL1 |
8454 |
Affinity Capture-MS |
|
Homo sapiens |
|
81 |
TFCP2 |
7024 |
Affinity Capture-MS |
|
Homo sapiens |
|
82 |
C7orf33 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
83 |
C5orf28 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
84 |
ICE2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
85 |
OCLM |
|
Affinity Capture-MS |
|
Homo sapiens |
| | | |